Breaking
Notable EconomicsCNBC (INT)

Novo says Wegovy injection lowers BMI and obesity rates in children in trial

Wegovy is already approved to treat obesity in children ages 12 and older, but there are currently no approved medications for those under 12.

Read the full story at CNBC ↗

ImpactNotable
Topics Obesity
Published9 h ago (Mon, 16 Nov 2026 15:00:01 GMT)
MoreLess
Impact score30/100
RatingProbability of 59%.
RegionsGlobal
Retrievedvia rss
ClassifiedMon, 16 Nov 2026 16:02:03 GMT by classifier